192 related articles for article (PubMed ID: 19846478)
1. Why should we compensate organ donors when we can continue to take organs for free? A response to some of my critics.
Cherry MJ
J Med Philos; 2009 Dec; 34(6):649-73. PubMed ID: 19846478
[TBL] [Abstract][Full Text] [Related]
2. Autonomy and organ sales, revisited.
Taylor JS
J Med Philos; 2009 Dec; 34(6):632-48. PubMed ID: 19880548
[TBL] [Abstract][Full Text] [Related]
3. Sociological and ethical issues in transplant commercialism.
Epstein M
Curr Opin Organ Transplant; 2009 Apr; 14(2):134-9. PubMed ID: 19307964
[TBL] [Abstract][Full Text] [Related]
4. A Catholic perspective on organ sales.
Capaldi N
Christ Bioeth; 2000 Aug; 6(2):139-51. PubMed ID: 12171074
[TBL] [Abstract][Full Text] [Related]
5. Body parts and the market place: insights from Thomistic philosophy.
Cherry MJ
Christ Bioeth; 2000 Aug; 6(2):171-93. PubMed ID: 12171076
[TBL] [Abstract][Full Text] [Related]
6. Incentivizing deceased organ donation: a Swedish priority-setting perspective.
Omar F; Tinghög G; Welin S
Scand J Public Health; 2011 Mar; 39(2):156-63. PubMed ID: 21239479
[TBL] [Abstract][Full Text] [Related]
7. Human organs, scarcities, and sale: morality revisited.
Kishore RR
J Med Ethics; 2005 Jun; 31(6):362-5. PubMed ID: 15923488
[TBL] [Abstract][Full Text] [Related]
8. Autonomy, moral constraints, and markets in kidneys.
Kerstein SJ
J Med Philos; 2009 Dec; 34(6):573-85. PubMed ID: 19846479
[TBL] [Abstract][Full Text] [Related]
9. Organ markets and the ends of medicine.
Davis FD; Crowe SJ
J Med Philos; 2009 Dec; 34(6):586-605. PubMed ID: 19880547
[TBL] [Abstract][Full Text] [Related]
10. A litmus test for exploitation: James Stacey Taylor's stakes and kidneys.
Kuntz JR
J Med Philos; 2009 Dec; 34(6):552-72. PubMed ID: 19880546
[TBL] [Abstract][Full Text] [Related]
11. Why not a kidney market? An obvious solution to the organ shortage.
Taylor JS
Free Inq; 2005; 25(5):42-3. PubMed ID: 16358474
[No Abstract] [Full Text] [Related]
12. Is a market in human organs necessarily exploitative?
Cherry MJ
Public Aff Q; 2000 Oct; 14(4):337-60. PubMed ID: 12564441
[No Abstract] [Full Text] [Related]
13. Organ markets and human dignity: on selling your body and soul.
Stempsey WE
Christ Bioeth; 2000 Aug; 6(2):195-204. PubMed ID: 12171077
[TBL] [Abstract][Full Text] [Related]
14. Incentivizing living organ donation.
Cynowiec J; Kim J; Qazi YA
Curr Opin Organ Transplant; 2009 Apr; 14(2):201-5. PubMed ID: 19300256
[TBL] [Abstract][Full Text] [Related]
15. Reconsidering Kantian arguments against organ selling.
Alpinar-Şencan Z
Med Health Care Philos; 2016 Mar; 19(1):21-31. PubMed ID: 25637083
[TBL] [Abstract][Full Text] [Related]
16. Incentives for organ donation in the United States: feasible alternative or forthcoming apocalypse?
Hippen B; Matas A
Curr Opin Organ Transplant; 2009 Apr; 14(2):140-6. PubMed ID: 19307965
[TBL] [Abstract][Full Text] [Related]
17. Commercial living non-related organ transplantation: a viewpoint from a developed country.
Hoyer PF
Pediatr Nephrol; 2006 Oct; 21(10):1364-8. PubMed ID: 16810510
[TBL] [Abstract][Full Text] [Related]
18. Scholarly watchdogs for an ethical netherworld: researchers form group to track and study sale of body parts for organ transplants.
Monaghan P
Chron High Educ; 2000 Oct; 47():A23-4. PubMed ID: 14598856
[No Abstract] [Full Text] [Related]
19. Issues in organ transplantation.
Colabawalla BN
Issues Med Ethics; 2001; 9(3):88-90. PubMed ID: 16334482
[No Abstract] [Full Text] [Related]
20. A matter of priority: transplanting organs preferentially to registered donors.
Kolber AJ
Rutgers Law Rev; 2003; 55(3):671-740. PubMed ID: 16189910
[No Abstract] [Full Text] [Related]
[Next] [New Search]
